LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$2.05
+0.02 (+0.74%)
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+776.6% upside
Low Target
$15.16
Average Target
$17.97
High Target
$22.64
Current Price
$2.05
Current
$2.05
$2.05
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Scenario Analysis
Bear Case
$15.16
639.5%
Low target
Base Case
$17.97
+776.6%
Avg target
Bull Case
$22.64
+1,004.4%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$2.68
-23.5% from high
52-Week Low
$1.06
+93.4% from low
Target vs 52W High
$17.97
+570.5% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |